Document Detail


Clinicopathological findings of bucillamine-induced nephrotic syndrome in patients with rheumatoid arthritis.
MedLine Citation:
PMID:  1799186     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This paper describes pathological and clinical investigations of glomerular lesions in bucillamine-induced nephropathy by analyzing biopsy materials from 9 patients with rheumatoid arthritis (RA). There was no specific predisposition for nephrotic syndrome induced by bucillamine in clinical profiles related to age, onset, duration of disease, sex, activity and dose of bucillamine. In light-microscopic, electron-microscopic and immunofluorescent findings, the characteristic changes were similar to those of idiopathic membranous glomerulonephritis (MGN). After discontinuance of bucillamine, the nephrotic syndrome improved slowly with or without corticosteroid therapy. Results confirmed that the most common lesion of nephrotic syndrome associated with bucillamine therapy in RA is MGN. We recommend that corticosteroid therapy should be restricted to cases with severe proteinuria.
Authors:
A Yoshida; K Morozumi; T Suganuma; K Sugito; M Ikeda; T Oikawa; T Fujinami; A Takeda; K Koyama
Related Documents :
9035166 - Superior vena cava thrombosis and chylothorax: relationship in pediatric nephrotic synd...
2797556 - Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic...
15146236 - Induction of b7-1 in podocytes is associated with nephrotic syndrome.
9370176 - Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biop...
10457616 - Studies on mitochondrial pathogenesis of rett syndrome: ultrastructural data from skin ...
11043436 - Conductive hearing loss and multiple pre- and supra-auricular skin defects: a variant e...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of nephrology     Volume:  11     ISSN:  0250-8095     ISO Abbreviation:  Am. J. Nephrol.     Publication Date:  1991  
Date Detail:
Created Date:  1992-04-14     Completed Date:  1992-04-14     Revised Date:  2007-02-14    
Medline Journal Info:
Nlm Unique ID:  8109361     Medline TA:  Am J Nephrol     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  284-8     Citation Subset:  IM    
Affiliation:
Third Department of Internal Medicine, Nagoya City University Medical School, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Inflammatory Agents, Non-Steroidal / adverse effects*,  therapeutic use
Arthritis, Rheumatoid / drug therapy*
Biopsy
Cysteine / adverse effects,  analogs & derivatives*,  therapeutic use
Female
Fluorescent Antibody Technique
Glomerulonephritis, Membranous / chemically induced*,  diagnosis
Humans
Kidney / pathology
Male
Microscopy, Electron
Middle Aged
Nephrotic Syndrome / chemically induced*,  diagnosis
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents, Non-Steroidal; 52-90-4/Cysteine; 65002-17-7/bucillamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Influence of therapy with recombinant erythropoietin on serum levels of neopterin in hemodialyzed su...
Next Document:  IgA antineutrophil cytoplasmic antibody in Henoch-Schönlein purpura.